Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kiyoi

Showing results (121-130 of 270) with videos related to

Pageof 27
Sort By:
Cell Stem Cell|June 7, 2024
Human iPSC-derived CD4<sup>+</sup> Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft modelHisashi Yano, Keiko Koga, Takayuki Sato, et al.
International Journal of Hematology|January 26, 2011
A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisisKatsuya Sakai, Yuichi Ishikawa, Yumiko Mori, et al.
Oncogene|May 17, 2021
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphomaShunsuke Kunou, Kazuyuki Shimada, Mika Takai, et al.
FEBS Open Bio|July 11, 2025
Two-way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3Reina Ueno, Aki Terasaki, Yuiko Imai, et al.
European Journal of Haematology|December 1, 2010
FLT3/ ITD regulates leukaemia cell adhesion through α4β1 integrin and Pyk2 signallingAkira Katsumi, Hitoshi Kiyoi, Akihiro Abe, et al.
European Journal of Haematology|December 17, 2009
BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4Momoko Suzuki, Akihiro Abe, Shizuka Imagama, et al.
International Journal of Hematology|November 29, 2008
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapyAkihiro Abe, Yosuke Minami, Fumihiko Hayakawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2021
Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T CellsShingo Okuno, Yoshitaka Adachi, Seitaro Terakura, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|December 10, 2019
Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with InhibitorsShuichi Okamoto, Nobuaki Suzuki, Atsuo Suzuki, et al.
International Journal of Hematology|September 28, 2019
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantationSonoko Kamoshita, Makoto Murata, Daisuke Koyama, et al.
Pageof 27

Showing results (121-130 of 270) with videos related to

Sort By:
Pageof 27
Cell Stem Cell|June 7, 2024
Human iPSC-derived CD4<sup>+</sup> Treg-like cells engineered with chimeric antigen receptors control GvHD in a xenograft modelHisashi Yano, Keiko Koga, Takayuki Sato, et al.
International Journal of Hematology|January 26, 2011
A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance: sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisisKatsuya Sakai, Yuichi Ishikawa, Yumiko Mori, et al.
Oncogene|May 17, 2021
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphomaShunsuke Kunou, Kazuyuki Shimada, Mika Takai, et al.
FEBS Open Bio|July 11, 2025
Two-way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3Reina Ueno, Aki Terasaki, Yuiko Imai, et al.
European Journal of Haematology|December 1, 2010
FLT3/ ITD regulates leukaemia cell adhesion through α4β1 integrin and Pyk2 signallingAkira Katsumi, Hitoshi Kiyoi, Akihiro Abe, et al.
European Journal of Haematology|December 17, 2009
BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4Momoko Suzuki, Akihiro Abe, Shizuka Imagama, et al.
International Journal of Hematology|November 29, 2008
Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapyAkihiro Abe, Yosuke Minami, Fumihiko Hayakawa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2021
Spacer Length Modification Facilitates Discrimination between Normal and Neoplastic Cells and Provides Clinically Relevant CD37 CAR T CellsShingo Okuno, Yoshitaka Adachi, Seitaro Terakura, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|December 10, 2019
Successful Perioperative Combination of High-Dose FVIII Therapy Followed by Emicizumab in a Patient with Hemophilia A with InhibitorsShuichi Okamoto, Nobuaki Suzuki, Atsuo Suzuki, et al.
International Journal of Hematology|September 28, 2019
Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantationSonoko Kamoshita, Makoto Murata, Daisuke Koyama, et al.
Pageof 27